Recent Headlines
AnaSpec Offers a Wide Selection of SYBR® qPCR MasterMixes and Core Kits
AnaSpec, EGT Group offers a wide selection of SYBR® Green-based MasterMixes and Core Kits for almost any thermocycler available in the industry. - January 12, 2013 - AnaSpec, EGT Group
Wescadia Group’s BioDeal 360™: Analysis of Deal Activity in the Australian Life Science Sector
Wescadia Group, a healthcare consultancy firm, announces the release of its report “BioDeal 360™”. The report provides strategic analysis, commentary, insight, and opinion on selected deals in the Australian life science industry in 2012. - December 19, 2012 - Wescadia Group Pty Ltd
Highly Sensitive SensoLyte® HDACs and HATs Assay Kits for Epigenetics Research
AnaSpec has developed a series of highly sensitive assay kits for the detection of the activities of HDAC (Histone Deacetylase), SIRT (Sirtuin) 1 & 2 or HAT (Histone Acetyltransferases). - December 07, 2012 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® ThT Aβ42 & Aβ40 Aggregation Kits
AnaSpec has developed the SensoLyte® ThT Aß40 and Aß42 Aggregation kits to provide a convenient and standard method for measurement of Aß40 and Aß42 aggregation, respectively. - December 06, 2012 - AnaSpec, EGT Group
BASF is Honored by Habitat for Humanity
BASF Named 2012 Sponsor of the Year by Habitat for Humanity - November 09, 2012 - BASF Corporation
BASF Donates $1,000 to Penrickton Center for Blind Children
BASF Wyandotte donates to Penrickton Center for Blind Children, located in Taylor, Michigan. - October 27, 2012 - BASF Corporation
OsoBio Appoints Alan P. Heim as Vice President of Human Resources
OSO BioPharmaceuticals Manufacturing, LLC, has appointed Alan P. Heim as vice president of human resources. In his capacity, Heim administers all policies and programs that affect personnel at OsoBio, including issues such as organizational planning; recruitment, hiring and training; employee... - October 05, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
SignaBlok Awarded NCI Grant to Test New Approach to Lung Cancer Treatment
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Cancer Institute (NCI) to develop novel and first-in-class agents in lung cancer. - October 03, 2012 - SignaBlok, Inc.
New Product Launch - Green Leaf Labs
Before the end of 2012 new N-(2-Hydroxyethyl) hexadecanamide products will be available worldwide with updated product specifications. - September 12, 2012 - Green Leaf Labs
AnaSpec Introduces SensoLyte® Enterokinase Assay Kits
AnaSpec, EGT Group is pleased to announce the release of two assay kits for quantitating enterokinase enzymatic activity – the SensoLyte® 520 and SensoLyte® Rh110 Enterokinase Activity Assay Kits. The former is a FRET (fluorescence resonance energy transfer)-based assay employing a... - August 30, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Speedy 28-Day Custom Polyclonal Antibody
When traditional protocols can take 70+ days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec, EGT Group asked, "Is there a way to develop custom antibodies faster without sacrificing quality in the finished product?" Here's the answer. The Speedy... - August 24, 2012 - AnaSpec, EGT Group
AnaSpec Offers Phosphospecific Antibodies Production
Cellular phosphorylation is a reversible, covalent modification of a protein or lipid that results in the modification of the activity of the phosphorylated molecule by inducing small conformational changes within the molecule.1-2 Catalyzed by protein kinases, phosphate groups can be added via the... - August 17, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Beta-Amyloid (1-40) Peptides
ß-Amyloid (1-40) together with ß-Amyloid (1-42) are two major C-terminal variants of the Aß protein constituting the majority of Aßs, with Ab (1-42) being more neurotoxic. These undergo post-secretory aggregation and deposition in the Alzheimer’s diseased... - August 01, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Beta-Amyloid (1-42) Peptides
Harnessing over a decade's worth of experience and a multi-level technology platform that includes peptides, antibodies, dyes and assay kits, AnaSpec, EGT Group is one of the world's most trusted sources of integrated proteomic solutions specifically designed for Alzheimer's Disease... - July 25, 2012 - AnaSpec, EGT Group
SignaBlok Awarded NIH Grant to Develop New Nanotechnology for Diagnostic Imaging of Atherosclerosis
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Institutes of Health (NIH) to develop multifunctional nanoformulations for diagnostic imaging of atherosclerosis. - July 12, 2012 - SignaBlok, Inc.
AnaSpec Introduces SensoLyte® Beta-Amyloid ELISA Kits
AnaSpec, EGT Group is pleased to announce the release of the SensoLyte® ELISA kits for the quantification of human and mouse/rat β-Amyloid (1-40) or (1-42) peptide. Compared to similar kits in the industry, these kits are a one-step assay optimized to detect human or mouse/rat beta-Amyloid... - June 29, 2012 - AnaSpec, EGT Group
AnaSpec Offers PTM Peptide Synthesis
Proteins undergo post-translational modifications (PTM) as a mechanism to expand the coding capacity of genes.1 PTMs found in histone “tails” (amino termini) such as acetylation, methylation and phosphorylation affect chromatin structure and exquisitely regulate gene... - June 27, 2012 - AnaSpec, EGT Group
AnaSpec Offers Industry’s Longest Wavelength Assay Kit for HDAC Dectection
Current HDAC assay kits have been based on a short wavelength substrate whose detection is darkened by the presence of autofluorescence interference. SensoLyte® has ushered in the dawn of ultra-sensitivity. AnaSpec, EGT Group’s SensoLyte® 520 HDAC Activity Assay Kit is the... - June 20, 2012 - AnaSpec, EGT Group
GenScript Launches a Premier Gene Synthesis Service "Gene-Bricktm" for Building Large DNA FragmentsTM
The Gene-BrickTM premier gene synthesis service is specifically designed to meet demands of large DNA fragments which are used in synthetic biology research, such as the building of large genetic circuits and synthetic chromosomes. - June 14, 2012 - GenScript USA Inc.
Inventys Research Butibori (Nagpur) Plant, Achieves ISO 9001:2008, ISO 14000:2004, and ISO 18000:OSHAS Certification
Inventys Research Company has achieved ISO 9001:2008, 14001:2004 and 18000:OSHAS Management System accreditation. The ISO 9001:2008 certification of compliance recognizes that the policies, practices, and procedures of Inventys ensure consistent quality in the products and services Inventys... - June 13, 2012 - Inventys Research Company Pvt Ltd.
AnaSpec Offers Anti-5-Methylcytidine (Clone 33D3)
AnaSpec, EGT Group is pleased to offer Eurogentec’s popular monoclonal antibody, anti-5-methylcytidine (Clone 33D3) for use in epigenetics research. Purified from ascites, this IgG1 / λ isotype antibody is supplied as a 1 mg/ml solution (in PBS) and is available in three sizes (0.1 mg,... - June 06, 2012 - AnaSpec, EGT Group
Royal Care Pharmacy (RCP) Joins PCCA
RCP is pleased to announce PCCA membership. - May 31, 2012 - Royal Care Pharmacy Inc
AnaSpec Offers a Wide Selection of GO® Histone Peptides
AnaSpec, EGT Group offers a wide selection of GO® (catalog) Histone peptides that are biotin-labeled. Single or combinations of post-translational modified (PTM) amino acid-containing biotinylated histone peptide sequences have been used in applications such as pull-down assays.1-2 Generally... - May 31, 2012 - AnaSpec, EGT Group
AnaSpec Showcases Fluorescent Nucleic Acid Probes
The detection of nucleic acids is important for many life science research tasks, such as sequencing, cDNA synthesis and cloning, RNA transcription and transfection. Accurate detection of DNA/RNA is key to the success of these techniques. DNA/RNA concentration is often measured by UV absorbance at... - May 19, 2012 - AnaSpec, EGT Group
AnaSpec Offers PEGylated Peptides Synthesis
PEGylation has become a well-accepted method for the delivery of biopharmaceuticals-especially peptide and protein drugs.1-4 Simple modification of a drug with polyethylene glycol (PEG) not only is capable of improving the drug’s solubility, diminishing the potential for aggregation, and... - May 16, 2012 - AnaSpec, EGT Group
Grand Rounds at Metropolitan Hospital - Compounding Options in Medicine: Special Focus on Physiatry
Dr Haldey, PharmD, President of Royal Care Pharmacy, Inc, will provide a comprehensive overview of pharmacy compounding with a specific focus on physiatry. - May 12, 2012 - Royal Care Pharmacy Inc
Royal Care Pharmacy Will Present at the 5th Annual Wound Symposium
Dr Emil Haldey, the Company’s President, has been invited to speak at the 5th Annual Wound Care Symposium sponsored by NY College of Podiatric Medicine and Nassau University Medical Center. Dr Emil Haldey will discuss history, rationale and benefits of pharmacy compounding for the modern podiatry practice. - May 12, 2012 - Royal Care Pharmacy Inc
AnaSpec Highlights SensoLyte® 520 Renin Assays for Human, Mouse & Rat Specific
AnaSpec, EGT Group, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit also provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using proprietary 5-FAM/QXL™ 520 fluorescence... - May 09, 2012 - AnaSpec, EGT Group
OSO BioPharmaceuticals Invests $5 Million in Aseptic Filling Suite
State-of-the-art line will increase capacity and yield of liquid, suspension and lyophilized products. - May 02, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Introduces Pancreatic β-Cells Specific Antibodies - Anti-hFXYD2γa
AnaSpec, EGT Group is pleased to announce the release of three antibodies (two monoclonal and one polyclonal) against FXYD2γa. FXYD2γa is a regulating subunit of the NA+-K+-ATPase and has been identified as a unique and specific pancreatic beta cell surface biomarker. In individuals... - April 19, 2012 - AnaSpec, EGT Group
RayBiotech, Inc. and Innopsys Announce Co-Marketing Partnership
RayBiotech, Inc. today announced that it has entered into a co-marketing partnership with Innopsys of Carbonne, France to promote the sales of RayBiotech’s G-Series and Quantibody series of antibody arrays and array testing services with Innopsys’ Innoscan laser microarray scanning... - April 13, 2012 - RayBiotech, Inc
AnaSpec Highlights HiLyte Fluor™ Dyes Collection for Labeling Amine and Thiol-Modified Oligos
AnaSpec is pleased to highlight their wide collection of amine and thiol reactive 6-isomeric dyes of fluoresceins and rhodamines, and AnaSpec’s own proprietary HiLyte Fluor™ dyes for labeling amine and thiol modified oligonucleotides. Fluorescent dye-labeled oligos are widely used as... - March 29, 2012 - AnaSpec, EGT Group
World Leaders to Address Challenges and Technology Breakthroughs in Sample Preparation for Pathogen Detection at 5th Sample Prep Conference in San Diego, May 3-4
Leading organizations from around the world will convene in San Diego for the Knowledge Foundation’s 5th Sample Prep conference which will take place at the Hilton Resort & Spa from May 3-4, 2012. - March 24, 2012 - Knowledge Foundation
AnaSpec Develops AMC Resins for SPPS
Peptide-7-amino-4-methylcoumarin conjugates (peptide-AMCs) are widely used as fluorogenic substrates to study proteases. The preparation of peptide-AMCs usually involves solution phase synthesis since AMC lacks an additional functional group for attachment to a solid support. Although solid-phase... - March 22, 2012 - AnaSpec, EGT Group
CPC Scientific Announces Its Peptide Facility Passes 2nd Successful FDA Inspection
CPC Scientific is pleased to announce that its 50,000 sf cGMP peptide facility has successfully passed a second US Food and Drug Administration (FDA) inspection. It involved the investigator inspecting CPC Scientific’s peptide production facilities, manufacturing processes, laboratory control... - February 27, 2012 - CPC Scientific
AnaSpec Offers Symmetric & Asymmetric Dimethylated Arginine in Histone Peptides Collection
AnaSpec, EGT Group offers one of the world’s largest selections of Histone GO® (catalog) peptides. The peptides include sequences containing modified amino acids such as methylated (Me1, Me2 and Me3) Lysine; phosphorylated Threonine (pThr) or Serine (pSer); deiminated Arginine (Cit). - February 23, 2012 - AnaSpec, EGT Group
OsoBio Appoints Marian Meyer Director of Labs
Meyer manages the company’s chemistry and microbiology labs, which are responsible for such quality-control services as materials testing and release, environmental monitoring and analytical methods compliance. - February 23, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Offers Special Pricing for MOG (1-125) Recombinant Proteins
AnaSpec, EGT the first provider of commercial MOG recombinant proteins is pleased to offer a 50% discount off on MOG (1-125) recombinant proteins through the month of February, 2012 to US and Canadian customers. Please mention code “rMOG50%” when ordering to get the discount. AnaSpec's... - February 16, 2012 - AnaSpec, EGT Group
Milton Boyer Named President of OSO BioPharmaceuticals Manufacturing
Boyer has been responsible for guiding business strategies and creating new growth opportunities at OsoBio since 2008 - February 15, 2012 - OSO BioPharmaceuticals Manufacturing, LLC
AnaSpec Introduces SensoLyte® Factor Xa Activity Assays – Industry’s First Fluorimetric Kits
AnaSpec, EGT Group is pleased to announce the release of the industry first fluorimetric Factor Xa activity assays - The SensoLyte® 520 Factor Xa Assay Kit and the SensoLyte® Rh110 Factor Xa Assay Kit. The SensoLyte® 520 Factor Xa Assay Kit employs a FRET (5-FAM/QXL™ 520)... - February 15, 2012 - AnaSpec, EGT Group
GenScript Was the Most Frequently Referred Biology Contract Research Organization by Peer-Reviewed Journal Articles in 2011
GenScript USA Inc., an internationally recognized biology contract research organization (CRO), became the most frequently referred biology CRO in the world by peer-reviewed journal articles in the year 2011. Ever since its inception from 2002, GenScript has been consistently providing biological... - February 03, 2012 - GenScript USA Inc.
AnaSpec Offers Antibodies Against the Hexa-His and GFP Tags
The introduction of tags, whether short peptides (6X-His, DYKDDDDK, c-myc) or proteins (green fluorescent protein – GFP, glutathione-s-transferase – GST) into recombinant proteins aids in the characterization, localization or purification of the recombinant expressed protein.1-3 As a... - February 03, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Calcein AM for Live Cell Staining
Calcein AM (Calcein acetoxymethyl ester), a non-fluorescent, cell permeable compound, converts to the strongly green fluorescent calcein when hydrolyzed by intracellular esterases in live cells.1-2 It is widely used for determining cell viability since the fluorescence intensity of calcein is... - February 02, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Atrial Natriuretic Peptides in GO® Collection
AnaSpec, EGT Group provides a wide range of GO® (catalog) natriuretic peptides for use in research laboratories. Their selection of atrial natriuretic peptides (ANPs) include the biologically active 1-28 amino acid peptide (human/porcine or rat sequences); shorter ANP fragments; and Biotin, FAM... - February 02, 2012 - AnaSpec, EGT Group
AnaSpec Expands SensoLyte® 520 Renin Assay Kits Collection
AnaSpec, the provider of the ultra-sensitive SensoLyte® 520 Human Renin Assay Kit now provides renin kits specific for mouse and rat - the SensoLyte® 520 Mouse Renin Assay Kit and SensoLyte® 520 Rat Renin Assay Kit. Using their proprietary 5-FAM/QXL™ 520 fluorescence resonance... - January 25, 2012 - AnaSpec, EGT Group
AnaSpec Introduces SensoLyte® α-Synuclein ELISA Assay
AnaSpec, EGT Group is pleased to announce the release of an ultrasensitive ELISA assay for quantitatingα-synuclein. The SensoLyte® α-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) provides a convenient and quantitative assay for determining α-Synuclein amount in cell and... - January 25, 2012 - AnaSpec, EGT Group
AnaSpec Offers Speedy 28-Day Custom Polyclonal Antibody Service
When traditional protocols can take almost 90 days, the wait for high-quality custom polyclonal antibodies can be excruciating. AnaSpec is pleased to introduce the Speedy 28-day custom polyclonal antibody service. Leveraging proven technology from Eurogentec, AnaSpec's parent company, this protocol... - January 25, 2012 - AnaSpec, EGT Group
AnaSpec Introduces Ultra-Sensitive SensoLyte® NADP/NADPH Assay Kit
AnaSpec, EGT Group, the provider of ultra-sensitive fluorimetric SensoLyte® line of assay kits is pleased to announce the release of the SensoLyte® Fluorimetric NADP/NADPH Assay Kit. This assay is a sensitive fluorimetric assay that detects NADP and NADPH without interfering with NAD/NADH. - January 19, 2012 - AnaSpec, EGT Group
AnaSpec Includes Ghrelin and Obestatin Peptides in GO® Collection
AnaSpec, EGT Group, a leading provider of integrated proteomic and genomic solutions, offers a wide range of ghrelin and obestatin GO® (catalog) peptides for research use. In 1999, Kojima and his group (1) reported the discovery of a growth hormone secretagogue that is involved in the release... - January 19, 2012 - AnaSpec, EGT Group
AnaSpec Highlights Its Proprietary HiLyte Fluor™ Dye Collection
AnaSpec, EGT Group’s proprietary HiLyte Fluor™ dyes are a series of excellent fluorescent labeling dyes with fluorescence emissions that span the full visible and near infrared spectrum. The hydrophilic property of most of the HiLyte Fluor™ dyes makes conjugations to protein... - January 17, 2012 - AnaSpec, EGT Group